Current and Emerging Treatment Options for Uterine Fibroids Mohamed AliMichaĆ CiebieraAyman Al-Hendy Review Article 03 November 2023 Pages: 1649 - 1675
HIV Pre-Exposure Prophylaxis: New and Upcoming Drugs to Address the HIV Epidemic Christina G. RiveraJohn D. ZeuliZelalem Temesgen Review Article 11 December 2023 Pages: 1677 - 1698
Aetiology of Significant Liver Test Abnormalities in a Single-Centre Cohort of People with Cystic Fibrosis Exposed to Elexacaftor/Tezacaftor/Ivacaftor, Utilizing the Updated RUCAM Daniel TewkesburyAndrew M. JonesPeter J. Barry Original Research Article 15 November 2023 Pages: 1699 - 1707
Gepirone Extended-Release: First Approval Susan J. Keam AdisInsight Report 11 December 2023 Pages: 1723 - 1728
Nedosiran: First Approval Yahiya Y. Syed AdisInsight Report Open access 07 December 2023 Pages: 1729 - 1733
Correction: Elacestrant: First Approval Sheridan M. Hoy Correction Open access 25 November 2023 Pages: 1735 - 1735
Correction to: Motixafortide: First Approval Sheridan M. Hoy Correction 07 December 2023 Pages: 1737 - 1737